Micro Emerging Active

JNJ ICOTYDE Mostra Promesse Nel Trattamento Della Psoriasi a Placche

New narrative with limited coverage — still forming.

Punteggio
0,3
Velocità
▲ 0,0
Articoli
1
Fonti
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis Neutral

Articoli Correlati

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

Nasdaq · Mar 28, 2026
Mixed

Cronologia

Prima apparizioneMar 28, 2026
Ultimo aggiornamentoMar 28, 2026